Anatara Lifesciences Ltd Stock: price and insider trades · Australia
1 insider bought shares over the last 90 days, the latest by John Michailidis, filed 24 Aug 2026.
Anatara Lifesciences Ltd: what insiders have been doing
Insider filings for Anatara Lifesciences Ltd are scarce in the ASX feed, the latest one published on 24 August 2026. This page will fill in as new trades are disclosed. These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
1 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleJohn Michailidis1 buy
Financial data
as of FY 2024FY ended June 2024 · cache
A$0.01
Analyst consensus
Income statement
EBITDA-A$2.1M
Net income-A$1.5M-293.1% margin
Valuation
P/Book4.5x
Beta0.65
Balance sheet & cash
Market capA$2.8M
Total debtA$65.8k
Free Cash Flow-A$1.2M
Profitability & ownership
ROE-149.6%
ROA-59.4%
% insiders33.4%
% institutions10.4%
Last declaration on 24 August 2026
Declarations1 total
- ▲Executives0ASX
1 of 1 declaration
About Anatara Lifesciences Ltd
ANR is a company listed on the XASX market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
